Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Eicosadienoic Acid has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Eicosadienoic acid, 20:2n-6, is formed when the elongase ELOVL5 adds two carbons to linoleic acid. Dietary linoleic acid supply therefore sets how much of it appears in tissue lipids. In practice most measured 20:2n-6 in humans comes from this elongation rather than from the diet.
Linoleic acid can either be desaturated by delta-6 desaturase toward GLA and then dihomo-gamma-linolenic acid, or elongated directly to 20:2n-6. The two routes draw on the same substrate pool, so a rise in 20:2n-6 often reflects flow through the elongation branch. Supplying GLA directly bypasses the desaturation step that is usually rate limiting.
The n-6 and n-3 families are elongated and desaturated by the same enzymes, and those enzymes prefer the n-3 substrates. Raising EPA and DHA intake therefore shifts the whole n-6 elongation series, including 20:2n-6, downward in membrane phospholipids. This is why fatty acid panels change across the board after fish oil rather than only in the n-3 columns.
Delta-6 and delta-5 desaturases lose activity in zinc deficiency, and the classic marker of that deficiency is an altered ratio between the 20-carbon n-6 fatty acids. When desaturation is impaired the elongation route becomes relatively more prominent. The relevance is to deficiency states, not to routine supplementation.
Desaturase activity in the n-6 series is reduced in vitamin B6 depletion, which changes the balance of 20-carbon products in tissue lipids. As with zinc, this describes what happens when status is inadequate rather than a reason to add more. The measured consequence is a shift in the fatty acid profile, a marker, not an outcome.
Any polyunsaturated fatty acid with two or more double bonds is subject to chain autoxidation in oils and in membranes. Alpha-tocopherol donates a hydrogen atom to break that chain. Oils rich in 20-carbon polyunsaturates carry tocopherols for this reason, whether naturally present or added.
Evening primrose oil is mostly linoleic acid with a GLA fraction, so it feeds both branches of the n-6 pathway, elongation and desaturation. Anyone taking it will shift their 20-carbon n-6 profile including 20:2n-6. Whether that shift matters clinically is not something the fatty acid measurement itself answers.
Arachidonic acid is the major 20-carbon n-6 product and the substrate for the eicosanoid enzymes. 20:2n-6 shares the same carbon number and the same lipid pools but is not a cyclooxygenase or lipoxygenase substrate in the same way. In a fatty acid panel the two move for related but distinct reasons.
Nothing specific on file for Eicosadienoic Acid. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 4 we read for Eicosadienoic Acid. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.